| Professional Clinical Positions |
| 1998 - Present |
Borland-Groover Clinic
836 Prudential Dr.
Suite 801
Jacksonville, Florida |
| 2006 - Present |
Director of Infusion Therapy Clinic
Borland-Groover Clinic
Jacksonville, Florida |
| 2006 - Present |
Director of IMID Clinic
(Immune Mediated Inflammatory Disorders)
Borland-Groover Clinic
Jacksonville, Florida |
|
|
| Postgraduate Education |
| 1994 - 1996 |
Gastroenterology Fellowship
Lenox Hill Hospital
Program Director: Burton I. Korelitz, MD
Endoscopy Program Director: Jerome Waye MD
New York, New York
Board Certified American Board of Internal Medicine
|
| 1990 - 1994 |
Residency
Internal Medicine
Lenox Hill Hospital
Program Director: Michael Bruno, MD
New York, New York
Board Certified American Board of Internal Medicine
|
|
|
| Medical Education |
| 1986 - 1990 |
DSackler School of Medicine
Tel Aviv University
Tel Aviv, Israel
Doctor of Medicine, 1990
|
|
|
| Undergraduate Education |
| 1978 - 1982 |
New York University
School of Arts and Sciences
New York, New York
Bachelor of Arts, 1982
|
|
|
| Affiliations |
| 1994 - Present |
Crohn's and Colitis Foundation of America |
|
|
| Licensure |
|
Licensed in Florida |
|
|
| Certification |
|
Board Certified - American Board of Internal Medicine, 1997, #159347 |
|
Board Certified - Gastroenterology, 1999 |
|
|
| Publications |
| Warman JI, Korelitz BI, Fleisher MR, Janardhanam R.
Cumulative experience with short- and long-term toxicity to 6-mercaptopurine in the treatment of Crohn's disease and ulcerative colitis.
J Clin Gastroenterol. 2003 Sep;37(3):220-5.
|
| Regueiro M, Valentine J, Plevy S, Fleisher MR, Lichtenstein GR.
Infliximab for treatment of pyoderma gangrenosum associated with inflammatory bowel disease.
Am J Gastroenterol. 2003 Aug;98(8):1821-6.
|
| Fleisher MR, Rubin SD, Levine AE.
The Myriad Manifestations of Crohn's Disease Responsive to Infliximab.
Therapeutic Options for Crohn's and Colitis: A Case-Based Approach. 2001 November
|
| Fleisher MR, Hopkins, K.
Infliximab in the Treatment of Crohn's Disease Complicated by Granuloma Annulare.
Therapeutic Options for Crohn's and Colitis: A Case-Based Approach. 2001 September
|
| Korelitz BI, Mirsky FJ, Fleisher MR, Warman JI, Wisch N, Gleim GW.
Malignant neoplasms subsequent to treatment of inflammatory bowel disease with 6-mercaptopurine.
Am J Gastroenterol. 1999 Nov;94(11):3248-53.
|
| Zlatanic J, Fleisher M, Sasson M, Kim P, Korelitz BI.
Crohn's disease and acute leukocytoclastic vasculitis of skin.
Am J Gastroenterol. 1996 Nov;91(11):2410-3. Review.
|
| Fleisher MR
Lending a hand.
Nursing. 1994 Jul;24(7):32T
|
| Fleisher MR.
A piece of my mind. Hands on.
JAMA. 1994 Mar 2;271(9):642.
|
| |
| Presentations |
| Safety of Infliximab in IBD Patients With Previously Treated NeoplasmsPoster Presentation DDW 2003 |
| Steroids Versus Infliximab: Efficacy and Swiftness of Induction to RemissionPoster Presentation DDW 2003 |
| Infliximab: Is it a 5-ASA and Antibiotics Sparing Drug in Crohn’s Disease?Poster Presentation DDW 2003 |
| Infliximab in the Treatment of IBD-Associated Psoriasis and Psoriasis-Associated IBDPoster Presentation ACG 2002 |
| Collagenous Colitis: Experiences of a Large Community-Based PracticePoster Presentation ACG 2002 |
| Antinuclear Antibody and Rheumatoid Factor Expression in IBD Patients During Severe PresentationsPoster Presentation DDW 2002 |
| Successful Treatment of IBD-Associated Pyoderma Gangrenosum with InfliximabPoster Presentation DDW 2002 |
| Infliximab in the Treatment of Steroid Refractory Erythema Nodosum of IBDPoster Presentation DDW 2002 |
| A Continuum of the Aspiration Technique in Biliary Type 3 Sphincter of Oddi Manometry Patients and the Incidence of PancreatitisPoster Presentation DDW 2002 |
| Infliximab in the Treatment of Crohn's Disease Complicated by Granuloma AnnularePoster Presentation, AAD National Conference 2001 |
| REMICADEÒ (Infliximab) in the Management of Pyoderma GangrenosumPoster Presentation, AAD National Conference 2001 |
| Infliximab in the Treatment of Steroid-Naïve Ulcerative Colitis. Poster Presentation, ACG National Conference 2001 |
| Infliximab in the Treatment of Crohn’s Disease: Is It a Steroid Sparing Agent or a Steroid Replacing Agent?Poster Presentation, ACG National Conference 2001 |
| A Case Report: Infliximab in the Treatment of Bechet’s SyndromePoster Presentation, ACG National Conference 2001 |
| Remicade in the Treatment of Refractory Extraintestinal Manifestationsof Crohn’s DiseasePoster Presentation, DDW 2001 |
| Malignant Neoplasms Subsequent to Treatment of Inflammatory Bowel Disease with 6 – MercaptopurineOral Presentation ACG National Conference 1996 |
| Intravenous ACTH versus Hydrocortisone in the Treatment of Hospitalized Patients with Crohn’s DiseaseOral Presentation ACG National Conference 1995 |
| Hypokalemia Due to Intravenous Hydrocortisone versus ACTH in the Treatment of Hospitalized Patients with Crohn’s DiseasePoster Presentation ACG National Conference 1995 |
